Longitudinal Changes in Nasal Airflow and Patient‐Reported Outcomes Following Acoustic Nasal Therapy: A Pilot Study
Loading...
Files
Size: 839.12 KB, File format: Adobe PDF
Date
Authors
Alao, Jude Oluwapelumi
Bartley, Jim
Puli'uvea, Chris
White, David
Lee, Kevin
Lau, Kelvin EM
Supervisor
Item type
Degree name
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Background and Aims
Acoustic nasal therapy has emerged as a potential non-pharmacological adjunct for allergic rhinitis (AR) and chronic rhinosinusitis (CRS), but longitudinal evidence on its effects on nasal airflow and patient-reported outcomes remains limited. This early-phase study evaluated changes in objective nasal airflow and symptom burden following a 4-week acoustic nasal therapy intervention and a follow-up period after treatment withdrawal.
Methods
A prospective single-arm quasi-experimental longitudinal pilot study was conducted in 30 adults with clinician-diagnosed or symptom-consistent AR and/or CRS. Participants used a bilateral intranasal acoustic device for 10 min twice daily for 4 weeks. Outcomes were assessed at baseline, post-treatment, and follow-up after discontinuation. The primary longitudinal outcomes were peak nasal inspiratory flow (PNIF) and Sino-Nasal Outcome Test-22 (SNOT-22) scores. Secondary variables of subgroup, adherence, correlation, responder, and multivariable analyzes were also explored.
Results
PNIF showed no significant change immediately post-intervention (−2.0 L/min, p = 0.67) but increased between post-treatment and follow-up (+12.2 L/min, p = 0.036); change from baseline to follow-up was not significant (+ 10.1 L/min, p = 0.069 after Holm adjustment). Symptom burden improved significantly during treatment (−15.43 points, p < 0.0001) but partially attenuated after discontinuation (+11.97 points, p = 0.0003), with no significant difference between baseline and follow-up (−3.47 points, p = 0.242). At post-treatment, 66.7% achieved the minimum clinically important difference, decreasing to 33.3% at follow-up. Objective airflow changes did not consistently align with symptom improvement.
Conclusion
This study provides early longitudinal evidence on acoustic nasal therapy in adults classified as having AR and/or CRS. Patient-reported symptoms improved during active treatment and attenuated after withdrawal, while changes in objective nasal airflow were less consistent. These hypothesis-generating findings support controlled studies to clarify efficacy, optimal dosing, and durability of response.
Description
Keywords
32 Biomedical and clinical sciences, 42 Health sciences, allergic rhinitis, nasal obstruction, patient-reported outcome measures, respiratory function tests, rhinosinusitis therapeutics
Source
Health Science Reports, ISSN: 2398-8835 (Print); 2398-8835 (Online), Wiley, 9(10). doi: 10.1002/hsr2.73303
Publisher's version
Rights statement
© 2026 The Author(s). Health Science Reports published by Wiley Periodicals LLC. This is an open access article.
Permanent link
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial-NoDerivatives License